Reuters logo
BRIEF-Shire, Impax settle litigation related to Adderall XR
February 8, 2013 / 1:06 PM / 5 years ago

BRIEF-Shire, Impax settle litigation related to Adderall XR

LONDON, Feb 8 (Reuters) - Shire PLC : * Unit has settled all pending litigation with Impax Laboratories * Litigation was over shire’s supply of an authorized generic version of

adderall xr * Shire will make a one-time cash payment to impax of $48.0 million * Charges will not change shire’s updated financial guidance for 2012 and 2013,

as provided on January 8, 2013 * Source text

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below